Drug Profile
Helicobacter pylori vaccine - Provalis
Alternative Names: HP0310; UlsatatLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Provalis
- Developer Provalis; University of Newcastle, Australia
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Helicobacter infections